Boston Scientific Corporation (LON:0HOY)
London flag London · Delayed Price · Currency is GBP · Price in USD
105.18
-0.38 (-0.36%)
At close: Aug 1, 2025

Boston Scientific Company Description

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide.

It operates in two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention portfolios; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, urinary and bowel dysfunction, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, penile implants, artificial urinary sphincter, laser system, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator systems, proprietary programming software, radiofrequency ablation, indirect decompression systems, and intraosseous nerve ablation and deep brain stimulation systems.

It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a left atrial appendage closure (LAAC) device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems.

In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat, and ease forms of cancer.

The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Boston Scientific Corporation
CountryUnited States
Founded1979
IndustryMedical - Equipment & Services
SectorHealthcare
Employees53,000
CEOMichael Mahoney

Contact Details

Address:
300 Boston Scientific Way
Marlborough, Delaware 01752-1234
United States
Phone508 683 4000
Websitebostonscientific.com

Stock Details

Ticker Symbol0HOY
ExchangeLondon Stock Exchange
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
ISIN NumberUS1011371077
SIC Code3845

Key Executives

NamePosition
Michael F. MahoneyChairman, President and Chief Executive Officer
Joseph M. FitzgeraldExecutive Vice President and Group President of Cardiology
Jeffrey B. Mirviss M.B.A.Executive Vice President and President of Peripheral Interventions
Arthur Crosswell ButcherExecutive Vice President and Group President of MedSurg and Asia Pacific
Jonathan R. MonsonExecutive Vice President and Chief Financial Officer
John Bradley SorensonExecutive Vice President of Global Operations
Emily M. WoodworthSenior Vice President, Global Controller and Chief Accounting Officer
Jodi Euerle EddySenior Vice President and Chief Information and Digital Officer
Vance R. Brown J.D.Senior Vice President, General Counsel and Corporate Secretary
Mary Beth MoynihanSenior Vice President of Market Access and Chief Marketing Officer